Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Cambay India Update

16 Mar 2022 07:00

RNS Number : 9460E
Oilex Ltd
16 March 2022
 

ASX-RNS Announcement

 

16 March 2022

 

ASX: OEX / AIM: OEX

Cambay India Update

 

Oilex Limited (Oilex or the Company) is providing the following update to its operations in India and in particular, with respect to the Cambay field development.

 

Following the Government of India Ministry of Petroleum and Natural Gas approval of the transfer of assignment of the 55% Participating Interest in the Cambay Field PSC held by Gujarat State Petroleum Corporation Ltd (GSPC) to Oilex (taking the Company's interest to 100%), the Company is finalising the completion accounts in conjunction with GSPC personnel with a view to completing the transaction at the end of March 2022.

 

The Gujarat Pollution Control Board (GPCB) is expected to approve the re-commencement of production on the Cambay field imminently. All necessary operational preparation, including system integrity checks and safety system validations, has been undertaken to allow for an immediate re-start of gas production from two wells (C-73 and C-77H) upon receipt of GPCB approval.

 

The Company continues to prepare for the C-77H re-frac operation. Tenders for all the required equipment and services have been received and evaluated during the last week. The global oil and gas services sector is facing an acute shortage of capacity following several years of reduced activity and India is suffering from these constraints. Specifically, there is a shortage of hydraulic fraccing pumping equipment as well as several other key services required for the C-77H re-frac. Oilex is in the process of finalising contracts with a current timeline of July 2022 for the re-frac operation. Following the re-frac, the C-77H well will need to be flowed to clean up the well bore and it will be 30-60 days before a stabilised gas flow level can be established to assess the level of success of the re-frac. Gas production will be processed on location and sold via the existing grid connection under a new gas sales agreement. Similarly, associated condensate production will be sold under a separate sales agreement.

 

The targeted new initial production rate from the two new re-frac zones is 2 mmsfd. A successful re-frac operation will enable the initiation of the full Cambay field development with two new horizontal and fracced wells planned for end of 2022 / Q1 2023, subject to funding. Oilex's project studies and experience from other stimulation projects result in an expectation of initial production rates of 4-5 mmscfd for new horizontal wells which will provide robust economics.

 

India is the third largest energy market in the world. Indian gas demand growth is outpacing domestic supply with circa 50% of gas requirements from LNG imports. Robust gas prices are underpinned by the high marginal cost of LNG imports.

 

Oilex's Chief Executive Officer, Roland Wessel, said:

 

"After a protracted hiatus, we are very pleased that gas and condensate production on the Cambay field is due to resume in the near future, thanks mainly due to the efforts of Oilex's India team. In addition, the Bedrock / Manan project management team are working assiduously to execute the C-77H re-frac as early as possible without compromising the technical approach to this key field development operation. My recent visit to the Oilex Baroda office and to the Cambay field demonstrated that Oilex has a professional and motivated team in India fully capable of developing and operating the Company's key Cambay asset. I look forward to updating investors as we make further progress."

 

For and on behalf of Oilex Ltd

 

Roland Wessel

Managing Director

For further information, please contact:

 

Investor Enquires

Oilex Ltd

Roland Wessel

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquiries (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230 UK

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGPURUWUPPUQQ
Date   Source Headline
14th May 20217:00 amRNSIssue of Securities and Appendix 2A
7th May 20217:00 amRNSNotice of General Meeting
6th May 20212:00 pmRNSPrice Monitoring Extension
6th May 20219:55 amRNSChange of Interests of Substantial Holder
30th Apr 20217:36 amRNSMarch 2021 Quarterly Report
29th Apr 202111:06 amRNSIssue of Securities
23rd Apr 202110:24 amRNSIssue of Securities
23rd Apr 20217:00 amRNSInd Govt approval of Cambay PSC Work Prog/Budget
21st Apr 20211:43 pmRNSAcquisition Funding Arranged
13th Apr 20217:00 amRNSBhandut PSC PI Sale Finalisation
7th Apr 20215:51 pmRNSIssue of Securities
6th Apr 202111:00 amRNSPrice Monitoring Extension
6th Apr 20219:05 amRNSSecond Price Monitoring Extn
6th Apr 20219:00 amRNSPrice Monitoring Extension
1st Apr 20219:32 amRNSUpdate Regarding Cambay Settlement
17th Mar 20217:00 amRNSAppendix 2A
16th Mar 20217:00 amRNSCorrection: Equity Issue
15th Mar 20217:19 amRNSHalf Year Accounts
15th Mar 20217:00 amRNSSeries D Loan Restructure and Equity Issue
17th Feb 20217:00 amRNSAppendix 3Y P Schwarz
17th Feb 20217:00 amRNSAppendix 3Y P Haywood
15th Feb 20217:59 amRNSUpdate on proposal to acq interest in Cambay PSC
15th Feb 20217:46 amRNSTrading Halt Request
12th Feb 20218:15 amRNSIssue of Securities and Appendix 2A
1st Feb 20217:00 amRNSDecember 2020 Quarterly Report
24th Dec 20207:00 amRNSSeries C Loan Extension
17th Dec 202011:20 amRNSExecutive Directors Contract Extensions
17th Dec 202010:51 amRNSIssue of Securities
16th Dec 20207:00 amRNSResults of Annual General Meeting
14th Dec 20207:00 amRNSCompletion of East Irish Sea Transaction P2446
16th Nov 20207:00 amRNS2020 Notice of Annual General Meeting
6th Nov 20207:55 amRNSCorrection Waiver Granted
5th Nov 20207:30 amRNSWaiver Granted
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Financial Report
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Announcement
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Chairmans Review
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Directors Report
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Business Review
30th Oct 20209:54 amRNSSeptember 2020 Quarterly Report
30th Oct 20209:37 amRNSSeries C Loan Restructure
15th Oct 20208:54 amRNSArmour Completion and Update on Projects
1st Oct 20207:08 amRNSAppendix 4G
1st Oct 20207:00 amRNSCorporate Governance Statement 2020
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report - Financial Report
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report - Directors Report
1st Oct 20207:00 amRNSUnaudited Annual Report 2020 - Announcement
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report - Business Review
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report -Chairmans Review
14th Sep 202012:17 pmRNSArmour Share Purchase Agreement – Update
10th Aug 20207:00 amRNSIssue of Securities and Appendix 2A

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.